2.07
price down icon1.90%   -0.04
after-market Handel nachbörslich: 2.03 -0.04 -1.93%
loading
Schlusskurs vom Vortag:
$2.11
Offen:
$2.11
24-Stunden-Volumen:
698.28K
Relative Volume:
0.85
Marktkapitalisierung:
$147.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.50M
KGV:
-0.8625
EPS:
-2.4
Netto-Cashflow:
$-114.31M
1W Leistung:
-11.91%
1M Leistung:
-2.82%
6M Leistung:
-0.96%
1J Leistung:
-35.11%
1-Tages-Spanne:
Value
$2.01
$2.13
1-Wochen-Bereich:
Value
$2.01
$2.365
52-Wochen-Spanne:
Value
$1.31
$3.8099

Nkarta Inc Stock (NKTX) Company Profile

Name
Firmenname
Nkarta Inc
Name
Telefon
(925) 407-1049
Name
Adresse
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
Mitarbeiter
157
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
NKTX's Discussions on Twitter

Vergleichen Sie NKTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NKTX
Nkarta Inc
2.07 149.86M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-15 Herabstufung William Blair Outperform → Mkt Perform
2024-10-09 Eingeleitet Rodman & Renshaw Buy
2024-08-14 Hochstufung Raymond James Outperform → Strong Buy
2024-03-22 Herabstufung Raymond James Strong Buy → Outperform
2022-12-22 Herabstufung Oppenheimer Outperform → Perform
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-07-28 Eingeleitet Needham Buy
2022-07-18 Eingeleitet SVB Leerink Outperform
2022-03-11 Eingeleitet Raymond James Outperform
2022-03-08 Eingeleitet H.C. Wainwright Buy
2022-01-06 Eingeleitet William Blair Outperform
2021-11-18 Eingeleitet SMBC Nikko Outperform
2021-07-16 Eingeleitet Oppenheimer Outperform
2020-08-04 Eingeleitet Cowen Outperform
2020-08-04 Eingeleitet Evercore ISI Outperform
2020-08-04 Eingeleitet Mizuho Buy
2020-08-04 Eingeleitet Stifel Buy
Alle ansehen

Nkarta Inc Aktie (NKTX) Neueste Nachrichten

pulisher
Nov 03, 2025

Will Nkarta Inc. stock split again soon2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Nkarta Inc. stock benefits from strong dollarJobs Report & AI Driven Stock Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is it time to cut losses on Nkarta Inc.Market Activity Report & Reliable Volume Spike Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Nkarta Inc. stock supported by strong fundamentalsIPO Watch & Safe Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Nkarta Inc. stock prediction for this weekJuly 2025 Snapshot & Target Return Focused Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using Python tools to backtest Nkarta Inc. strategiesJuly 2025 Intraday Action & Community Trade Idea Sharing - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Nkarta Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Risk adjusted return profile for Nkarta Inc. analyzedBond Market & Capital Protection Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Nkarta Inc. stock continue upward momentumRisk Management & Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time alert setup for Nkarta Inc. performancePortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Nkarta Inc. stock deliver strong dividend growthWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Will Nkarta Inc. stock gain from government policiesPortfolio Update Summary & Safe Capital Investment Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Nkarta Inc Stock Analysis and ForecastGrowth vs. Value Investing & Low Cost Market Strategies - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Nkarta (NASDAQ:NKTX) - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

What drives Nkarta Inc stock priceRisk Mitigation Techniques & Low Entry Cost Investments - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Can machine learning forecast Nkarta Inc. recoveryJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Nkarta Inc. stock chart pattern explainedProduct Launch & Short-Term Trading Opportunity Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Nkarta Inc. stock sustain high P E ratiosJuly 2025 Action & Expert Curated Trade Setups - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Nkarta to Participate in November Investor Conferences - Bluefield Daily Telegraph

Oct 30, 2025
pulisher
Oct 30, 2025

Nkarta (NKTX) to Release Earnings on Thursday - MarketBeat

Oct 30, 2025
pulisher
Oct 28, 2025

What momentum indicators show for Nkarta Inc. stockTrade Signal Summary & Expert Approved Momentum Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Nkarta, Inc. Advances CAR NK Cell Therapy Study for Immune-Mediated Diseases - MSN

Oct 28, 2025
pulisher
Oct 28, 2025

Why Nkarta Inc. stock is a must watch in 20252025 Buyback Activity & Fast Momentum Stock Entry Tips - fcp.pa.gov.br

Oct 28, 2025

Finanzdaten der Nkarta Inc-Aktie (NKTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):